Please login to read the full article.
Scrip Regulatory Affairs
Stakeholders support exemption of in-house IVDs from EU directive, with conditions
01 March 2011
Amanda Maxwell
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- European Commission issues much-awaited guide on regulating standalone software as medical devices/IVDs
- Brand vs generic: the battle rages over EU anti-counterfeit 'safety features'
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
